SCHEMBL42016

SCHEMBL42016

CCCCCCCCCCCCCCCCCCCC(N)=O

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SOAT1 P35610 2/20 0.74
MEN1 O00255 2/20 0.74
KMT2A Q03164 2/20 0.74
FAAH O00519 1/20 0.74
TP53 P04637 1/20 0.74
CYP1A2 P05177 1/20 0.74
CYP3A4 P08684 1/20 0.74
CYP2C19 P33261 1/20 0.74
KDM4E B2RXH2 2/20 0.65
CES2 O00748 3/20 0.65
CES1 P23141 3/20 0.65
GPR84 Q9NQS5 7/20 0.62
PPARG P37231 6/20 0.62
PPARD Q03181 6/20 0.62
PPARA Q07869 6/20 0.62
HDAC11 Q96DB2 5/20 0.62
TSHR P16473 4/20 0.62
ALDH1A1 P00352 2/20 0.62
TLR2 O60603 2/20 0.62
TDP1 Q9NUW8 2/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL216219 1.00 SOAT1 (0.74) SOAT1MEN1KMT2AFAAHTP53
SCHEMBL2048989 1.00 SOAT1 (0.74) SOAT1MEN1KMT2AFAAHTP53
Hexane SCHEMBL9626247 1.00 SOAT1 (0.74) SOAT1MEN1KMT2AFAAHTP53
SCHEMBL218192 1.00 SOAT1 (0.74) SOAT1MEN1KMT2AFAAHTP53
SCHEMBL8743286 1.00 SOAT1 (0.74) SOAT1MEN1KMT2AFAAHTP53
SCHEMBL42192 1.00 SOAT1 (0.74) SOAT1MEN1KMT2AFAAHTP53
SCHEMBL6046254 1.00 SOAT1 (0.74) SOAT1MEN1KMT2AFAAHTP53
Palmitamide SCHEMBL43384 1.00 SOAT1 (0.74) SOAT1MEN1KMT2AFAAHTP53
Octadecanoic Acid Amide SCHEMBL8417300 1.00 SOAT1 (0.74) SOAT1MEN1KMT2AFAAHTP53
SCHEMBL22319678 1.00 SOAT1 (0.74) SOAT1MEN1KMT2AFAAHTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1582 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260008911-A1 COMPOSITION BOREALIS AG (AT) 2026-01-08 US claimed
US-20250387313-A1 HYALURONIC ACID HYDROGEL WITH CERAMIDE BONDED THERETO AMOREPACIFIC CORPORATION (KR) 2025-12-25 US claimed
EP-4306442-B1 COMPOSITION BOREALIS AG (AT) 2025-05-07 EP claimed
CN-116515204-B Fiber sliding masterbatch composition and preparation method and application thereof 金发科技股份有限公司 2025-04-18 CN claimed
EP-4306444-B1 COMPOSITION BOREALIS AG (AT) 2025-03-05 EP claimed
CN-119119721-A Anti-blocking and smooth nylon master batch and preparation method and application thereof 佛山佛塑科技集团股份有限公司 2024-12-13 CN claimed
WO-2024233871-A1 ORGANOTIN PHOTORESIST COMPOSITION AND METHOD OF STABILIZATION LU FENG (US) 2024-11-14 WO claimed
US-20240377729-A1 ORGANOTIN PHOTORESIST COMPOSITION AND METHOD OF STABILIZATION LU FENG (US) 2024-11-14 US claimed
CN-118717556-A Bionic sebum composition containing dihydromyricetin and application thereof 广东芭薇生物科技股份有限公司 2024-10-01 CN claimed
CN-118697654-A Bionic sebum composition containing dihydroquercetin and application thereof 广东芭薇生物科技股份有限公司 2024-09-27 CN claimed
EP-1968761-A1 METALLURGICAL POWDER COMPOSITION HÖGANÄS AB (SE) 2008-09-17 EP claimed
WO-2007108982-A2 IMPROVED LUBRICANT COMPOSITION FOR CELLULOSIC-THERMOPLASTIC COMPOSITE CHEMTURA CORPORATION (US) 2007-09-27 WO claimed
WO-2007078232-A1 METALLURGICAL POWDER COMPOSITION HÖGANÄS AB (SE) 2007-07-12 WO claimed
EP-0886551-B1 STABILITY CONTROL AGENT COMPOSITION FOR POLYOLEFIN FOAM KNAUS DENNIS A (US) 2004-08-04 EP claimed
US-5180761-A Solid lubricants treated with titanates or silane compounds NATIONAL SCIENCE COUNCIL (TW) 1993-01-19 US claimed
EP-0107850-B1 AMINOGLYCOSIDE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1988-04-06 EP claimed
US-4493831-A ANTIBIOTICS, VIRICIDES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1985-01-15 US claimed
US-4467024-A Process for the production of thermo-developable type diazo copying material RICOH CO., LTD. (JP) 1984-08-21 US claimed
EP-0107850-A1 Aminoglycoside derivatives, processes for their preparation and pharmaceutical compositions containing them FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1984-05-09 EP claimed
US-4367275-A Method of preventing offset of electrostatic images after fixing and developing using polyvalent metal salt polymer in toner DAINIPPON INK & CHEMICALS, INC. (JP) 1983-01-04 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260008911-A1 COMPOSITION ACTR3, ACTR2, MACF1 SOAT1 4240/4885MEN1 3826/4885KMT2A 2882/4885
US-20240377729-A1 ORGANOTIN PHOTORESIST COMPOSITION AND METHOD OF STABILIZATION NCLN, NCL, RPS13 SOAT1 396/4885MEN1 3411/4885KMT2A 2202/4885
US-20250387313-A1 HYALURONIC ACID HYDROGEL WITH CERAMIDE BONDED THERETO CERS2, CERT1, ASAH2 SOAT1 801/4885MEN1 4815/4885KMT2A 1672/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.